HEALTHMEDPAGE TODAY
Can a Betting Market Offer Hope to a Cancer Patient?
Kalshi, a prediction markets operator, announced it will allow customers to bet on whether late-stage clinical trials will meet their primary endpoints. This initiative is described as a limited roll-out.
Related Signal
Adjacent reporting
- Prediction market wagering on drug approvals draws fire from researchers
- Prediction market Kalshi to give $2m to problem gambling group as it fights ‘gambling’ label
- Prediction markets surge in US as public health advocates call for support to combat gambling
- LA therapists are seeing more young patients with gambling problems. They blame Kalshi
- STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals